The Charles R. Bronfman Institute of
Personalized Medicine www.mountsinai.org/personalizedmedicine
The Charles R. Bronfman Institute for Personalized Medicine (IPM) at The Mount Sinai Medical Center in Manhattan will help propel Mount Sinai to the forefront of personalized medicine, an emerging field that uses information about a person's genetic make-up to customize strategies for the detection, treatment, and prevention of disease. The $12.5 million ACBP gift will be used to fund an institution-wide Biobank at Mount Sinai and to establish the Translational Biomedical Informatics Center, two areas of focus for the Institute for Personalized Medicine, seed-funding Mount Sinai's overall $30 million personalized medicine initiative. The grant will be paid out over a period of 10 years.
Landmark discovery efforts in genome and information sciences have provided life scientists with powerful tools for gaining a deeper understanding of the role genes and environment play in health and disease. Personalized medicine transforms the traditional "one-size-fits-all" model of medicine by incorporating each individual's unique genomic make-up and environmental exposure to better manage their disease predispositions or diseases. The Institute examines how this new model of genome-informed personalized healthcare may be translated in clinical settings to advance the practice, delivery and economics of health care.